Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)
Trial details
- Registry ID
- NCT05658510
- Drugs studied
- BXCL501
TrialRedline tracks 7 clinical trials sponsored by BioXcel Therapeutics Inc: 5 Phase 3, 2 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)NCT05658510 | BXCL501 | Completed | 2025-08-15Actual |
| Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)NCT05271552 | BXCL501 | Completed | 2023-04-21Actual |
| Dexmedetomidine in the Treatment of Agitation Associated With Bipolar DisorderNCT04276883 | Sublingual film containing Dexmedetomidine (BXCL501) | Completed | 2020-05-21Actual |
| Dexmedetomidine in the Treatment of Agitation Associated With SchizophreniaNCT04268303 | Sublingual film containing dexmedetomidine (BXCL501) | Completed | 2020-05-06Actual |
| Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)NCT05665088 | BXCL501 | Terminated | 2023-09-11Actual |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar DisorderNCT07116694 | BXCL501 Sublingual Film | Completed | 2025-10-07Actual |
| An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With DementiaNCT05276830 | BXCL501 | Terminated | 2022-04-01Actual |
Names as written in the registry records.
NCT05665088 · BioXcel Therapeutics Inc
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Change from baseline in Positive and Negative Syndrome Scale- Excited Component (PEC) total score Description: The Positive and Negative Syndrome Scale - Excited Component (PEC) comprises 5 items associated with agitation: poor impulse control, tension, hostility, uncooperativeness, and excitement; each scored 1 (minimum) to 7 (maximum). The PEC, the sum of these 5 subscales, thus ranges from 5 (absence of agitation) to 35 (extremely severe) Time frame: 120 minutes post-dose for first episode of agitation. After: Measure: Change From Pre-dose in PEC Total Score at 30 Minutes Post-dose for the First Treated Episode of Agitation Description: The PEC includes 5 items-poor impulse control, tension, hostility, uncooperativeness, and excitement-each of which is rated from 1 (minimum) to 7 (maximum); the sum of these 5 items the PEC total score, ranges from 5 (absence of agitation) to 35 (extremely severe). Lower score indicated better outcome. Time frame: Pre-dose, 30 minutes post-dose Measure: Change From Pre-dose in PEC Total Score at 1 Hour Post-dose for the First Treated Episode of Agitation Description: The PEC includes 5 items-poor impulse control, tension, hostility, uncooperativeness, and excitement-each of which is rated from 1 (minimum) to 7 (maximum); the sum of these 5 items, the PEC total score ranges from 5 (absence of agitation) to 35 (extremely severe). Lower score indicated better outcome. Time frame: Pre-dose, 1 hour post-dose Measure: Change From Pre-dose in PEC Total Score at 2 Hours Post-dose for the First Treated Episode of Agitation Description: The PEC includes 5 items-poor impulse control, tension, hostility, uncooperativeness, and excitement-each of which is rated from 1 (minimum) to 7 (maximum); the sum of these 5 items, the PEC total score ranges from 5 (absence of agitation) to 35 (extremely severe). Lower score indicated better outcome. Time frame: Pre-dose, 2 hours post-dose Measure: Change From Pre-dose in PEC Total Score at 4 Hours Post-dose for the First Treated Episode of Agitation Description: The PEC includes 5 items-poor impulse control, tension, hostility, uncooperativeness, and excitement-each of which is rated from 1 (minimum) to 7 (maximum); the sum of these 5 items, the PEC total score ranges from 5 (absence of agitation) to 35 (extremely severe). Lower score indicated better outcome. Time frame: Pre-dose, 4 hours post-dose Measure: Change From Pre-dose in PEC Total Score at 8 Hours Post-dose for the First Treated Episode of Agitation Description: The PEC includes 5 items-poor impulse control, tension, hostility, uncooperativeness, and excitement-each of which is rated from 1 (minimum) to 7 (maximum); the sum of these 5 items, the PEC total score ranges from 5 (absence of agitation) to 35 (extremely severe). Lower score indicated better outcome. Time frame: Pre-dose, 8 hours post-dose Measure: Change From Pre-dose in PEC Total Score at 12 Hours Post-dose for the First Treated Episode of Agitation Description: The PEC includes 5 items-poor impulse control, tension, hostility, uncooperativeness, and excitement-each of which is rated from 1 (minimum) to 7 (maximum); the sum of these 5 items, the PEC total score ranges from 5 (absence of agitation) to 35 (extremely severe). Lower score indicated better outcome. Time frame: Pre-dose, 12 hours post-dose Measure: Change From Pre-dose in PEC Total Score at 24 Hours Post-dose for the First Treated Episode of Agitation Description: The PEC includes 5 items-poor impulse control, tension, hostility, uncooperativeness, and excitement-each of which is rated from 1 (minimum) to 7 (maximum); the sum of these 5 items, the PEC total score ranges from 5 (absence of agitation) to 35 (extremely severe). Lower score indicated better outcome. Time frame: Pre-dose, 24 hours post-dose.
NCT07116694 · BioXcel Therapeutics Inc
Before: Estimated. After: Actual.
Before: 30 participants (planned). After: 33 participants (actual).
Before: Estimated. After: Actual.
Before: Oct 2025. After: 7 Oct 2025.
Before: Active not recruiting. After: Completed.
NCT05271552 · BioXcel Therapeutics Inc
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Absolute change from baseline in Positive and Negative Syndrome Scale- Excited Component (PEC) total score. After: Measure: Absolute Change From Baseline in Positive and Negative Syndrome Scale- Excited Component (PEC) Total Score for the First Episode of Agitation.